A synthetic drug that controls blood sugar in obese mice demonstrates the potential of a DNA-dependent method for developing new chemical compounds.
I was in Harrisburg, PA lecturing this weekend. I received the USA Today newspaper on Friday May 16, 2014 and on page 5A there was an article titled, “Life Expectancy Up; Japanese Females Living Longest of All.”
The Obama administration received clear notice more than 5 years ago that VA medical facilities were reporting inaccurate waiting times and experiencing scheduling failures that threatened to deny veterans timely health care
On a farm about six miles outside this gambling town, Jason Chamberlain looks over a flock of about 50 smelly sheep, many of them possessing partially human livers, hearts, brains and other organs. The University of Nevada-Reno researcher talks matte
High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email email@example.com to buy additional rights.
Attorney Marc J. Victor will be on Fox and Friends Monday morning at 6 am Arizona Time to discuss the class action lawsuit to be filed against The Veterans Administration.
For Drudge Report founder, Matt Drudge, his distrust of the media, his feeling that the American press is chock full of government double-agents was finally proven.
A group of engineers at Stanford has developed an iPad-sized, highly power-efficient way of simulating a million neurons and billions of synapses for as low as US$400.
Christina Lunka appeared nervous and excited as she sat in the Chinese herbal therapy center recently opened by the Cleveland Clinic.
Building Trust International has announced the winners of its 2014 Moved To Care competition.
Scientists from South Korea have devised a technique for cloning adult stem cells that doesn't involve the destruction of human embryos.
Up Close, Personal, and Bloody
We’ve all come to accept the notion that our brain will continue to shrink as we age. Nowhere is this decline more impactful than in the hippocampus, the brain’s memory center, one of the primary brain areas that’s first to decline in Alzheimer’s dis
We heart this idea
Then again, Australia still thinks it's a good idea to cull sharks.
Kathleen Sebelius has resigned as Secretary of Health and Human Services, a White House official confirmed.
A chemical trigger regrows the thymus of a living mouse
More people consider spring their favorite season over any other.
Don’t Send Them Money for Breast Cancer Research… Send Them Your Bra!
Yale had been telling Chan she might be forced to leave school if she didn’t put on some pounds. “It felt really bad to be this powerless,” Chan said. “I ate ice cream twice a day. I ate cookies. I used elevators instead of walking up stairs. But I d
Uh-oh. Apparently a recent study yet to be expanded on indicates that men who carry cell phones in their pockets for a good portion of the day have a higher risk of getting erectile dysfunction
The XStat syringe stops bleeding in 15 seconds using tiny sponges.
The CEO of the Cleveland Clinic says that a majority of Americans who signed up for Obamacare have seen their premiums rise.
A British man reportedly amputated his own hand after he claimed hospitals refused to perform the operation for him.
A top of advisor to President Barack Obama is in Los Angeles to try to get Obamacare written into scripts of TV shows and movies. Valerie Jarrett explained in an appearance on Top That! on PopSugar.com:
U.S. Secretary of Health and Human Services Kathleen Sebelius visited Nashville on Thursday to urge Tennesseans to sign up for insurance through the federal health care exchange before a March 31 deadline.
David Irvine (CEO of MaidSafe.Com), a fully decentralized internet platform on which application developers can build decentralized applications - Jean Swann (VIce Pres on Integrated Health International respectively) on the
Did anyone really doubt that the final Obamacare enrollment deadline would slip, too?
At Gilead Sciences, they’re popping champagne corks. They’ve got a blockbuster drug, a once in a lifetime winner, Sovaldi. As FiercePharma reports: “With a revolutionary approach to hepatitis C and a price tag of $84,000 per 12-week treatment cour